tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments
PremiumRatingsOptimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments
25d ago
DBV Technologies announces last patient visit completed in VITESSE trial
Premium
The Fly
DBV Technologies announces last patient visit completed in VITESSE trial
1M ago
DBV Technologies appoints Kevin Trapp as chief commercial officer
Premium
The Fly
DBV Technologies appoints Kevin Trapp as chief commercial officer
1M ago
DBV Technologies to sell $30M of ADSs through at-the-market program
PremiumThe FlyDBV Technologies to sell $30M of ADSs through at-the-market program
2M ago
DBV Technologies’ Viaskin Peanut Program: Strategic Advancements and Regulatory Pathways Pave the Way for Investment Opportunities
Premium
Ratings
DBV Technologies’ Viaskin Peanut Program: Strategic Advancements and Regulatory Pathways Pave the Way for Investment Opportunities
5M ago
DBV Technologies: Advancing Viaskin Peanut Towards FDA Approval with Strong Financial Backing
Premium
Ratings
DBV Technologies: Advancing Viaskin Peanut Towards FDA Approval with Strong Financial Backing
5M ago
Cautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
PremiumRatingsCautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
7M ago
DBV Technologies reinstated with a Sell at Goldman Sachs
Premium
The Fly
DBV Technologies reinstated with a Sell at Goldman Sachs
7M ago
DBV Technologies price target raised to $21 from $15 at Citizens JMP
Premium
The Fly
DBV Technologies price target raised to $21 from $15 at Citizens JMP
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100